Deprescribing in advanced illness.
Patients with advanced illness such as cancer, chronic obstructive pulmonary disease, and Parkinson's disease experience acute symptoms and are usually prescribed medications to manage these, alongside drugs to treat other co-morbid, long-term conditions. As such, the pharmacotherapeutic burden for...
| Publicado en: | Progress in Palliative Care Vol. 24; no. 5; pp. 268 - 272 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Taylor & Francis Ltd
Oct2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=117922303&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 117922303 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09699260 131V jtl: Progress in Palliative Care issn: 09699260 maglogo: N pubinfo: dt: Oct2016 vid: 24 iid: 5 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 117922303 10.1080/09699260.2016.1192321 117922303 ppf: 268 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Deprescribing in advanced illness. aug: au: Akinbolade, Olusola Husband, Andy Forrest, Simon Todd, Adam affil: School of Medicine, Pharmacy and Health, Durham University, UK sug: subj: Polypharmacy Neoplasms Drug Therapy Pulmonary Disease, Chronic Obstructive Drug Therapy Parkinson Disease Drug Therapy Drug Therapy Decision Making, Clinical ab: Patients with advanced illness such as cancer, chronic obstructive pulmonary disease, and Parkinson's disease experience acute symptoms and are usually prescribed medications to manage these, alongside drugs to treat other co-morbid, long-term conditions. As such, the pharmacotherapeutic burden for these patients is high and polypharmacy is common. Previous studies have revealed the prevalence of potentially inappropriate prescribing within this group of patients, and identified the need for attention to ‘deprescribing’. Deprescribing can be defined as a process of optimization of medication regimens through cessation of potentially inappropriate or unnecessary medications. Patients usually have reservations about taking medications and may be willing to discontinue one or more medications considered ‘inappropriate’. Similarly, healthcare professionals experience some challenges discussing deprescribing approaches to patients with advanced illness. This article reviews research on prescribing medicines to patients with advanced illness, focusing on the identification of the prevalence of inappropriate or unnecessary medicines to the initiation of the deprescribing process. The review demonstrates the paramount importance of further research exploring the perspective of healthcare professionals and patients on the subject of deprescribing to facilitate its further acceptance in practice. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|